Left Behind? Drug Discovery in Extensive Stage Small Cell Lung Cancer

מאת Riess, Jonathan W., Lara, Primo N.
יצא לאור 2014

Advances in targeting acquired resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors

מאת Chen, Justin A., Riess, Jonathan W.
הוצא לאור ב J Thorac Dis (2020)

The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era

מאת Lwin, Zarnie, Riess, Jonathan W., Gandara, David
יצא לאור 2013

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer

מאת Riess, Jonathan W., Lara, Primo N., Gandara, David R.
הוצא לאור ב J Clin Oncol (2016)

A Patient with Anaplastic Lymphoma Kinase (ALK) FISH Positive NSCLC with Development of Leptomeningeal Carcinomatosis while on Targeted Treatment with Crizotinib

מאת Riess, Jonathan W., Nagpal, Seema, Neal, Joel W., Wakelee, Heather A.
הוצא לאור ב J Natl Compr Canc Netw (2013)

A Population-Based Study of Incidence and Survival of 1,588 Thymic Malignancies: Results from the California Cancer Registry

מאת Benjamin, David J., Klapheke, Amy, Lara, Primo N., Cress, Rosemary D., Riess, Jonathan W.
הוצא לאור ב Clin Lung Cancer (2019)

A Case Series of NSCLC Patients with Different Molecular Characteristics and Choroidal Metastases: Improvement in Vision withTreatment Including Pemetrexed and Bevacizumab

מאת Riess, Jonathan W, Nagpal, Seema, Das, Millie, Neal, Joel W., Kim, Jonathan W., Wakelee, Heather A.
יצא לאור 2013

Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug–drug interaction

מאת Das, Millie, Padda, Sukhmani K., Frymoyer, Adam, Zhou, Lisa, Riess, Jonathan W., Neal, Joel W., Wakelee, Heather A.
הוצא לאור ב Lung Cancer (2015)

GLI1, CTNNB1 and NOTCH1 Protein Expression in a Thymic Epithelial Malignancy Tissue Microarray

מאת Riess, Jonathan W., West, Robert, Dean, Michelle, Klimowicz, Alex C., Neal, Joel W., Hoang, Chuong, Wakelee, Heather A.
הוצא לאור ב Anticancer Res (2015)

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck

מאת Trieu, Vanessa, Pinto, Harlan, Riess, Jonathan W., Lira, Ruth, Luciano, Richard, Coty, Jessie, Boothroyd, Derek, Colevas, A. Dimitrios
הוצא לאור ב Oncologist (2018)

Prolonged Survival of Non-Small Cell Lung Cancer Patients With Leptomeningeal Carcinomatosis in the Modern Treatment Era

מאת Riess, Jonathan W., Nagpal, Seema, Iv, Michael, Zeineh, Michael, Gubens, Matthew A., Ramchandran, Kavitha, Neal, Joel W., Wakelee, Heather A.
הוצא לאור ב Clin Lung Cancer (2014)

A Case Series of Lengthy Progression-Free Survival With Pemetrexed-Containing Therapy in Metastatic Non–Small-Cell Lung Cancer Patients Harboring ROS1 Gene Rearrangements

מאת Riess, Jonathan W., Padda, Sukhmani K., Bangs, Charles D., Das, Millie, Neal, Joel W., Adrouny, Adour R., Cherry, Athena, Wakelee, Heather A.
יצא לאור 2013

Diffuse High Intensity PD-L1 Staining in Thymic Epithelial Tumors

מאת Padda, Sukhmani K., Riess, Jonathan W., Schwartz, Erich J., Lu, Tian, Kohrt, Holbrook E., Neal, Joel W., West, Robert B., Wakelee, Heather A.
הוצא לאור ב J Thorac Oncol (2015)

A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS

מאת Riess, Jonathan W., Jahchan, Nadine S., Das, Millie, Koontz, M. Zach, Kunz, Pamela L., Wakelee, Heather A., Schatzberg, Alan, Sage, Julien, Neal, Joel W.
הוצא לאור ב Cancer Treat Res Commun (2020)

Phase 1 Study of Alisertib (MLN8237) and Weekly Irinotecan in Adults with Advanced Solid Tumors

מאת Semrad, Thomas J., Kim, Edward J., Gong, I-Yeh, Li, Tianhong, Christensen, Scott, Arora, Mili, Riess, Jonathan W., Gandara, David R., Kelly, Karen
הוצא לאור ב Cancer Chemother Pharmacol (2021)

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

מאת Ho, Cheryl, Davies, Angela M., Sangha, Randeep S., Lau, Derick, Lara, Primo, Chew, Helen K., Beckett, Laurel, Mack, Philip C., Riess, Jonathan W., Gandara, David R.
הוצא לאור ב Invest New Drugs (2013)

Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC

מאת Cheng, Michael L., Lau, Christie J., Milan, Marina S. D., Supplee, Julianna G., Riess, Jonathan W., Bradbury, Penelope A., Jänne, Pasi A., Oxnard, Geoffrey R., Paweletz, Cloud P.
הוצא לאור ב JCO Precis Oncol (2021)

Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders

מאת Leonardi, Giulia C., Gainor, Justin F., Altan, Mehmet, Kravets, Sasha, Dahlberg, Suzanne E., Gedmintas, Lydia, Azimi, Roxana, Rizvi, Hira, Riess, Jonathan W., Hellmann, Matthew D., Awad, Mark M.
הוצא לאור ב J Clin Oncol (2018)

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database

מאת Padda, Sukhmani K., Yao, Xiaopan, Antonicelli, Alberto, Riess, Jonathan W., Shang, Yue, Shrager, Joseph B., Korst, Robert, Detterbeck, Frank, Huang, James, Burt, Bryan M., Wakelee, Heather A., Badve, Sunil S.
הוצא לאור ב J Thorac Oncol (2017)

Oral 1.01: Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies

מאת Wakelee, Heather A., Padda, Sukhmani K., Burns, Matthew, Spittler, A. J., Riess, Jonathan W., San Pedro-Salcedo, Melanie, Ramchandran, Kavitha J., Gubens, Matthew A., Neal, Joel W., Loehrer, Patrick J.
הוצא לאור ב J Thorac Dis (2015)